Pharming (PHAR) Shares Outstanding (2020 - 2025)

Pharming's Shares Outstanding history spans 6 years, with the latest figure at $701.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $701.7 million for Q4 2025, up 3.14% from a year ago — trailing twelve months through Dec 2025 was $701.7 million (up 3.14% YoY), and the annual figure for FY2025 was $701.7 million, up 3.14%.
  • Shares Outstanding for Q4 2025 was $701.7 million at Pharming, up from $680.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $701.7 million in Q4 2025 to a low of $648.7 million in Q4 2021.
  • The 5-year median for Shares Outstanding is $671.1 million (2023), against an average of $671.6 million.
  • The sharpest move saw Shares Outstanding decreased 14.82% in 2021, then grew 3.14% in 2025.
  • Year by year, Shares Outstanding stood at $648.7 million in 2021, then increased by 1.17% to $656.3 million in 2022, then grew by 2.24% to $671.1 million in 2023, then grew by 1.38% to $680.3 million in 2024, then increased by 3.14% to $701.7 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $701.7 million, $680.3 million, and $671.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.